Disclosed herein are novel nucleic acid molecules which encode novel polypeptides for use in treating polyglutamine diseases such as Huntingtons disease. The polypeptides of the invention exhibit reduced immunotoxity in vivoand may have utility in sustained (mid-or long-term) expression